Back to home

    NOVA

    SN68

    Evaluation Score

    Overall rating on a scale of 0-10

    RiskReturn
    05.310
    Risk Level:
    Very High
    Recommendation:Speculative position only
    Evaluated:August 27, 2026 (v14)

    Dimension Breakdown

    Development Activity6.5
    Community HealthN/A
    Tokenomics5.0
    Market & Use Case4.0
    Team & GovernanceN/A
    Security & AuditsN/A

    AI Analysis

    Comprehensive evaluation of the token

    SN68 (NOVA) is a Bittensor subnet-68 token oriented toward ML-driven drug screening and biologics discovery. Active Development scored 6.5/10 due to an active GitHub repository (metanova-labs/nova) and recent ecosystem coverage highlighting an operational subnet and roadmap. Tokenomics scored 5.0/10, reflecting a deflationary mechanism with a 450M burn out of a 500M total supply and vote-escrow mechanics, balanced against supply discrepancy concerns and Bittensor dependency risks. Market and Use Case scored 4.0/10 due to low daily trading volume ($213K-$320K), a 64% drawdown from ATH, and minimal social presence. Significant data gaps exist: Community Support (-1.0), Team and Governance (-1.0), and Security and Audit History (-1.0) all suffered from severe search-term contamination from unrelated entities sharing the 'Nova' name, leaving those dimensions unverified. No qualifying red-flag events were established.

    Development Activity

    Code updates and developer engagement

    RiskReturn
    06.510

    Community Support

    Social media presence and community engagement

    Insufficient Data

    Tokenomics

    Supply, distribution, and utility

    RiskReturn
    05.010

    Market & Use Case

    Value proposition and competitive landscape

    RiskReturn
    04.010

    Team & Governance

    Team background and project governance

    Insufficient Data

    Security & Audits

    Security history and audit status

    Insufficient Data

    About NOVA (SN68)

    SN68 (NOVA) is a native subnet token operating on Bittensor as subnet 68 (netuid 68). The project is oriented toward machine learning-driven drug screening and biologics discovery, maintained under the metanova-labs/nova repository within the Bittensor ecosystem. The token model features a deflationary supply architecture, incorporating a 450 million token burn out of a 500 million total minted supply alongside vote-escrow mechanics and permanent burn-locks for voting privileges.

    The project's market presence is characterized by low liquidity and a significant price drawdown. Trading with a market capitalization between $23 million and $25 million and daily volumes around $213,000 to $320,000, NOVA has experienced a price decline of approximately 64% from its all-time high of $14.03 recorded on June 10, 2025.

    Evaluation of the project reveals several structural and operational risks. These include dependency on the Bittensor subnet framework, material discrepancies in supply figures between documentation and market trackers, and limited vesting disclosures. Furthermore, public data concerning the development team's identity, formal governance structures, independent security audit verifications, and community engagement metrics remain undetermined due to substantial data gaps.

    Similar Rated Tokens